6 Flashcards

1
Q

Secretory Glands

Can self regulate, but affected by the

A

ANS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sympathetic system:

A

epinephrine, norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Parasympathetic system:

A

acetylcholine (muscarinic receptors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Somatic system:

A

acetylcholine (nicotinic receptors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adrenergic transmission

Transmitter transported back into the

A

presynaptic terminus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cholinergic transmission

Neurotransmitter hydrolyzed in

A

synapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sympathomimetic

A

Sympathetic PNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Endogenous Adrenergic Amines made in

A

sympathetic nerve terminals and in the adrenal medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

alpha1 receptors

A

Most important place - smooth muscle cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

alpha 1 receptors all coupled to

A

Galphaq - leads to smooth muscle contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Alpha 1 receptors increase

A

Calcium, activity of yosin light chain kinase, myosin light chain phosphorylation, overall contractility.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

a2 receptors

Most important at

A

presynaptic termini

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

a2 receptors inhibit

A

epinephrine and norepinephrine release (CNS and PNS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

b2 receptors on smooth muscle cells increase

A

PKA,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

b2 receptors phosphorylate and inhibit

A

myosin light chain kinase,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

b2 receptors diminish —— levels and inhibit

A

Ca++

myosin light chain kinase (next slide),

17
Q

b2 receptors diminish phosphorylation of

A

myosin light chain and decrease muscle contractility

18
Q

cAMP activates PKA which, in turn, inhibits

A

MLCK. Inhibition of MLCK diminishes myosin light chain phosphorylation and diminishes smooth muscle contraction (i.e. ‘causes’ dilation).

19
Q

b1 receptors on cardiac muscle cells (mainly b1 but also b2) activate

A

PKA, activate L type Ca++ channels,

20
Q

b1 receptors increase

A

Ca++ levels and increase muscle contractility

21
Q

Cardiac effects Mainly

A

b1 effects. b2 effects contribute to epinephrine activity.

22
Q

Non vascular smooth muscle

Usually relaxation mediated by

A

b2 receptors. GI decreased motility. Broncho dilation. However, a receptors mediate sphincter contraction

23
Q

Salivary Glands

Net effect:

A

Modest secretion with a high concentration of protein.

Mainly a1 and b1 with some b2. b1 stimulates protein secretion

24
Q

Intravenous administration of epi and norepi

A

you get anxiety, jitters, apprehension in spite of bbb not allowing it through.

25
Q

Endogenous agonists

A

dopamine, epi, norepi

26
Q

Dopamine mainly important in

A

CNS

27
Q

Anaphylaxis:

A

severe whole body response to allergen
Smooth muscle constriction
Vasodilation (severe hypotension)
Increased vascular permeability

28
Q

Epinephrine (intramuscular injection) standard emergency treatment Stimulation of a receptors:

A

Increase blood pressure

29
Q

Epinephrine (intramuscular injection) standard emergency treatment
Stimulation of b1 receptors:

A

Positive cardiac effects

30
Q

Epinephrine (intramuscular injection) standard emergency treatment Stimulation of b2 receptors:

A

Bronchodilation

31
Q

a1 receptor agonists

These drugs act primarily to produce

A

contraction of vascular smooth muscle, resulting in an increase in blood pressure. Some are contained in commonly used oral or topical decongestants or in eye drops (diminish bloodshot eyes).

32
Q

Levonordefrin is sometimes used as a

A

vasoconstrictor in conjuction with a local anesthetic.

33
Q

Metaraminol is used to treat

A

t hypotension during surgery.

34
Q

Vasoconstrictors in Dental Practice Epinephrine (common) levonordefrin (less common) used in conjunction with local anesthetic. Why?

A
  1. Prolong the duration of nerve block and might improve the likelihood of success of nerve block. 2. Diminish systemic toxicity of the anesthetic 3. Minimize blood loss during surgical procedure
35
Q

a2 receptor agonists

The drugs are thought to primarily act in the central nervous system by inhibiting

A

epinephrine and norepinephrine release from presynaptic termini. This can produce a wide variety of effects. Some agonists (e.g. clonidine, guanabenz, guanfacine, and methyldopa) are used to treat hypertension via autonomic regulation of the cardiovascular system*. Others act as a muscle relaxant (e.g. tizanidine). Others are used to treat ADHD (clonidine) or as a sedative (dexmedetomidine).

36
Q

b1 receptor agonists

These drugs are used primarily in the treatment of

A

heart failure and cardiogenic shock via direct stimulation of b1 receptors.

37
Q

b2 agonists These drugs produce

A

smooth muscle relaxation. They are used primarily to treat respiratory disease (e.g. asthma) but can be used to produce vasodilation in muscle and liver and to produce relaxation of uterine tissue.

38
Q

Non-selective a adrenergic receptor antagonists blcok

A

transmitter mediated feedback loop